Vimta Labs enterprise value

Share price at each year-end

Tap a line for its trend	Currentlast 12M	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus


2,322	—	—	—	—	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
52.5	25.0	15.8	12.1	29.6
3.3	3.3	8.5	19.2	15.0
2,273	—	—	—	—
−49.2	−21.6	−7.3	7.1	−14.6
₹508.78	—	—	—	—

495	460	387	335	296
0.7%	0.7%	2.2%	5.7%	5.1%
0.00×	—	—	—	—

5.30×	—	—	—	—
15.28×	—	—	—	—
22.80×	—	—	—	—
48.01×	—	—	—	—
429	407	344	313	315
149	142	122	83.6	93.5
99.7	97.7	86.7	49.6	63.0
—	147	94.6	59.1	86.5
47.3	47.3	15.1	−16.3	36.7
—	47.2	14.8	−16.7	36.5
—	99.8	79.5	75.4	49.8

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

VIMTALABS₹519.80

Vimta Labs Limited

· Pharma & Health

₹ CrorePeersSUVEN TAKEMcap ₹2,322 Cr

HighlightsEnterprise Value Multiples Per ShareAnnuals · FY-end closes

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Current/LTM TTM · last close
Market Capitalization	—	—	—	—	2,321.9
- Cash, Equiv & ST Investments	29.6	12.1	15.8	25.0	52.5
+ Total Debt	15.0	19.2	8.5	3.3	3.3
Enterprise Value	—	—	—	—	2,272.7
Net Debt (memo)	-14.6	7.1	-7.3	-21.6	-49.2
EV per Share	—	—	—	—	508.78

Total Capital	295.6	335.5	387.4	460.2	494.7
Total Debt/Total Capital	5.07	5.72	2.20	0.72	0.67
Total Debt/EV	—	—	—	—	0.00

EV/Sales	—	—	—	—	5.30
EV/EBITDA	—	—	—	—	15.28
EV/EBIT	—	—	—	—	22.80
EV/Free Cash Flow	—	—	—	—	48.01
Reference Items — Trailing FY Values
Sales	315.1	312.9	344.0	407.3	428.9
EBITDA	93.5	83.6	121.9	141.5	148.8
EBIT	63.0	49.6	86.7	97.7	99.7
Operating Cash Flow	86.5	59.1	94.6	147.1	—
Free Cash Flow	36.7	-16.3	15.1	47.3	47.3
FCFF (free cash flow to the firm)	36.5	-16.7	14.8	47.2	—
Capital Expenditure	49.8	75.4	79.5	99.8	—

Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.